Log in to save to my catalogue

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine...

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_18608214

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

About this item

Full title

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

Publisher

New York: Nature Publishing Group US

Journal title

Nature medicine, 2002-01, Vol.8 (1), p.68-74

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Diffuse large B-cell lymphoma (DLBCL), the most common lymphoid malignancy in adults, is curable in less than 50% of patients. Prognostic models based on pre-treatment characteristics, such as the International Prognostic Index (IPI), are currently used to predict outcome in DLBCL. However, clinical outcome models identify neither the molecular bas...

Alternative Titles

Full title

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_18608214

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_18608214

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/nm0102-68

How to access this item